These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 4250052)
1. Studies on vaccination against cholera. VI. Toxicity of V. cholerae suspensions killed by various methods. Joó I; Pusztai Z; Juhász VP Z Immunitatsforsch Allerg Klin Immunol; 1970 Apr; 139(3):265-76. PubMed ID: 4250052 [No Abstract] [Full Text] [Related]
2. Studies on vaccination against cholera. V. Mouse protective ability of V. cholerae suspensions killed by various methods. Joó I; Pusztai Z; Juhász VP Z Immunitatsforsch Allerg Klin Immunol; 1969 Jul; 138(3):254-63. PubMed ID: 4241064 [No Abstract] [Full Text] [Related]
3. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines. Cryz SJ; Fürer E; Germanier R Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478 [TBL] [Abstract][Full Text] [Related]
4. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase. Stewart-Tull DE; Lucas C; Bleakley CR Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770 [TBL] [Abstract][Full Text] [Related]
5. [Developmental aspects of organism immunoreactivity in vaccination against cholera (author's transl)]. Gorkova AV; Kuznĕcov OR; Naumsina MS; Adamov AK Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):136-42. PubMed ID: 126811 [No Abstract] [Full Text] [Related]
6. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge. Kundu J; Mazumder R; Srivastava R; Srivastava BS FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752 [TBL] [Abstract][Full Text] [Related]
8. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477 [TBL] [Abstract][Full Text] [Related]
9. Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier. Chernyak A; Kondo S; Wade TK; Meeks MD; Alzari PM; Fournier JM; Taylor RK; Kovác P; Wade WF J Infect Dis; 2002 Apr; 185(7):950-62. PubMed ID: 11920320 [TBL] [Abstract][Full Text] [Related]
10. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897 [TBL] [Abstract][Full Text] [Related]
11. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera]. María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578 [TBL] [Abstract][Full Text] [Related]
12. Live attenuated oral cholera vaccines. Ryan ET; Calderwood SB; Qadri F Expert Rev Vaccines; 2006 Aug; 5(4):483-94. PubMed ID: 16989629 [TBL] [Abstract][Full Text] [Related]
13. [The new ("El Tor") cholera pandemic. Epidemiology, clinical aspects, possibilities of immunoprophylaxis]. Raettig H Munch Med Wochenschr; 1965 Oct; 107(44):2153-8. PubMed ID: 5899032 [No Abstract] [Full Text] [Related]
14. SEROLOGICAL STUDIES ON CHOLERA. II. ANTIBODY LEVELS OBSERVED IN EXPERIMENTALLY VACCINATED MONKEYS. BERAN GW Am J Trop Med Hyg; 1964 Sep; 13():708-15. PubMed ID: 14205891 [No Abstract] [Full Text] [Related]
15. [New knowledge on the pathogenesis of cholera. Consequences for active vaccination]. Emmerling P; Finger H Munch Med Wochenschr; 1972 May; 114(19):911-3. PubMed ID: 5068367 [No Abstract] [Full Text] [Related]
16. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003. Kabir S Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687 [No Abstract] [Full Text] [Related]
18. A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice. Pérez JL; Acevedo R; Callicó A; Fernández Y; Cedré B; Año G; González L; Falero G; Talavera A; Pérez O; García L Vaccine; 2009 Jan; 27(2):205-12. PubMed ID: 18996426 [TBL] [Abstract][Full Text] [Related]
19. [Current problems of epidemiology and prevention of El Tor cholera]. Teodorovici G Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):1-7. PubMed ID: 5552559 [No Abstract] [Full Text] [Related]
20. Intestinal colonization of the infant mouse model by attenuated and virulent Vibrio cholerae strains. Cedré Marrero B; García Imia LG; García Sánchez HM; Fariñas Medina M; Talavera Coronel A; Infante Bourzac JF Arch Med Res; 1998; 29(3):231-4. PubMed ID: 9775456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]